Questions about ACR 2024

What strategies or initiatives do you think could be most effective in addressing the rheumatology workforce shortage?

This question is part of our collaboration with ACR Convergence 2024 to Continue the Conversation from the meeting. This question was inspired by...

3 Answers available

How do you screen rheumatoid arthritis patients for lung disease (modality, frequency, patient selection)?

This question is part of our collaboration with ACR Convergence 2024 to Continue the Conversation from the meeeting. This question was inspired by the...

5 Answers available

What is the role of the rheumatologist in recommending and providing GLP-1 medications to their patients given the benefits across many disease domains including osteoarthritis?

This question is part of our collaboration with ACR Convergence 2024 to Continue the Conversation from the meeting. This question was inspired by the ...

1 Answer available

What is the most impactful career advice you have received from a colleague or mentor?

This question is part of our collaboration with ACR Convergence 2024 to Continue the Conversation from the meeting. This question was inspired by the ...

6 Answers available

How long do you continue rituximab in patients with ANCA associated vasculitis who have achieved remission?

What information do you use to make this determination? Do you tend to transition to an oral agent like azathioprine after discontinuation to prevent ...

2 Answers available

How do you determine which patients with ANCA associated vasculitis may be good candidates for reduced dose glucocorticoid tapering?

This question is part of our collaboration with ACR Convergence 2024 to Continue the Conversation from the meeeting. This question was inspi...

1 Answer available

Do you continue biologics in sJIA patients who develop lung disease on anti IL-1 or anti IL-6 therapies?

This question is part of our collaboration with ACR Convergence 2024 to Continue the Conversation from the meeting. This question was inspired by the ...

2 Answers available

What is your approach to screening patients with sJIA for associated lung disease?

Do you universally screen? What prompts you to screen when you do? This question is part of our collaboration with ACR Convergence 2024 to Co...

1 Answer available

ACR 2024

Questions discussed in this category

Papers discussed in this category

Related Topics